ABSTRACT

Sitruk-Ware, Régine and Pirjo Inki. 2005. "The levonorgestrel intrauterine system: Long-term contraception and therapeutic effects," Women's Health 1(2): 171–182. (PDF posted with permission from Women's Health © Future Medicine Ltd, 2005)

The levonorgestrel intrauterine system (Mirena®) has been developed as a long-acting method of contraception. This medicated device, inserted into the uterus, delivers a small daily dose of a progestin, levonorgestrel, into the uterine cavity. It is one of the most effective methods of contraception and is approved in more than 100 countries for 5 years of use.

Return to Product Research and Development Publications/Resources page

---